Physician profile
Vikki L Sutterfield
NPI 1447247267
$9,023.53
in general payments reported to CMS, 2019-2025
42 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $1,163 · 2021: $1,472 · 2022: $1,404 · 2023: $1,159 · 2024: $1,257 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,721.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,172.32 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,162.47 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Pfizer INC. | $703.69 | 2019-2025 | |
| Amgen INC. | $693.88 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $651.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $523.61 | 2019-2022 | |
| Astellas Pharma US INC | $460.29 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $380.57 | 2021-2025 | |
| Abbott Laboratories | $344.36 | 2020-2025 | Freestyle Libre, Freestyle Libre 3 |
| Lilly USA, LLC | $331.36 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Allergan, INC. | $311.09 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $228.59 | 2022-2025 | Rexulti |
| Glaxosmithkline, LLC. | $222.43 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $217.69 | 2019-2024 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $191.79 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikki Sutterfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.